Status:
COMPLETED
ITV Extension Study
Lead Sponsor:
Kirby Institute
Collaborating Sponsors:
The University of New South Wales
Virax Pty. Ltd,
Conditions:
HIV
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The objective of this phase I/II therapeutic human immunodeficiency virus (HIV) vaccine candidate study is to provide proof of concept for a HIV antigen delivery system in terms of safety, virological...
Detailed Description
A multi-centre, double-blind, placebo-controlled, 20-week parallel group extension study to the VIR-NCHR-01 protocol (ITV study). The purpose of the extension study is to assess the safety and virolog...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- HIV-1 infected individuals eligible and still fulfilling the criteria for the VIR-NCHR-01 protocol (ITV study)
- Received all 3 immunisations
- Remained in follow-up for at least 52 weeks
- Continued to take combination antiretroviral therapy with no evidence of treatment failure at the time entering the roll-over phase
- Written informed consent obtained
- Criteria for Withdrawal of Study Participants
- Incidental or progression of disease which, in the opinion of the principal investigator, should preclude further study participation
- If the study participant required cytotoxic or immunosuppressive chemo- or radiation therapy
- If the study participant required any medications that when combined with the study vaccination, would in the opinion of the principal investigator, jeopardise the validity of the individual's continued participation
- Administration of prohibited alternative therapy
- Study participant non-compliance
- All study participants are required to adhere to the protocol evaluation schedule. Failure to adhere with this schedule without having first provided justification may result in the participant being withdrawn from the study
- At the request of the study participant or principal investigator without prejudice to future health care
- In the opinion of the investigator, if it is not in the patient's best interests to continue the study
- At the request of the National Centre in HIV Epidemiology and Clinical Research (NCHECR) with reasonable cause
- At the advice of the Data Safety Monitoring Board (DSMB)
Exclusion
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
End Date :
September 1 2003
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00332930
Start Date
September 1 2002
End Date
September 1 2003
Last Update
February 27 2007
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
407 Doctors
Sydney, New South Wales, Australia, 2010
2
Ground Zero Medical Practice
Sydney, New South Wales, Australia, 2010
3
Holdsworth House Medical Practice
Sydney, New South Wales, Australia, 2010
4
St Vincents Hospital
Sydney, New South Wales, Australia, 2010